Viewing StudyNCT00375505



Ignite Creation Date: 2024-05-05 @ 5:02 PM
Last Modification Date: 2024-10-26 @ 9:27 AM
Study NCT ID: NCT00375505
Status: COMPLETED
Last Update Posted: 2015-09-07
First Post: 2006-09-11

Brief Title: The Safety and Efficacy of Zoledronic Acid in the Prevention of Cancer Therapy Induced Bone Loss
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Breast Cancer
Keywords:
Name View
Breast Cancer View
Premenopausal View
Bone mineral density View
Cancer therapy induced bone loss View
zoledronic acid View